Deletion of the α8 integrin gene does not protect mice from myocardial fibrosis in DOCA hypertension

American Journal of Hypertension

Volumn 22, Issue 1, 2009, Pages 92-99

  Hartner, Andrea ^a   Cordasic, Nada ^a   Rascher, Wolfgang ^a   Hilgers, Karl F ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; DEOXYCORTICOSTERONE ACETATE; DISCOIDIN; FIBRONECTIN; INTEGRIN ALPHA 8; OSTEOPONTIN; UNCLASSIFIED DRUG; DEOXYCORTICOSTERONE; DNA; INTEGRIN ALPHA8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE DELETION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; GENE EXPRESSION; GENETICS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; DNA; ENDOMYOCARDIAL FIBROSIS; GENE EXPRESSION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA CHAINS; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE DELETION;

EID: 57749206812     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.309     Document Type: Article

References (38)

1. Hsueh WA, Law RE, Do YS. Integrins, adhesion, and cardiac remodeling. Hypertension 1998; 31:176-180.
2. Fogo AB. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol 1999; 7:147-159.
3. Scoazec JY. Expression of cell-matrix adhesion molecules in the liver and their modulation during fibrosis. J Hepatol 1995; 22:20-27.
4. Giancotti FG. A structural view of integrin activation and signaling. Dev Cell 2003; 4:149-151.
5. Norman JT, Fine LG. Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp Nephrol 1999; 7:167-177.
6. Sheppard D. Functions of pulmonary epithelial integrins: from development to disease. Physiol Rev 2003; 83:673-686.
7. Hahm K, Lukashev ME, Luo Y, Yang WJ, Dolinski BM, Weinreb PH, Simon KJ, Chun Wang L, Leone DR, Lobb RR, McCrann DJ, Allaire NE, Horan GS, Fogo A, Kalluri R, Shield CF 3rd, Sheppard D, Gardner HA, Violette SM. Alpha v beta 6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol 2007; 170:110-125.
8. Popov Y, Patsenker E, Stickel F, Zaks J, Bhaskar KR, Niedobitek G, Kolb A, Friess H, Schuppan D. Integrin alpha v beta 6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol 2008; 48:453-464.
9. Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z, Devitt ML, Horan GS, Weinreb PH, Lukashev ME, Violette SM, Grant KS, Colarossi C, Formenti SC, Munger JS. Inhibition of integrin alpha v beta 6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med 2008; 177:82-90.
10. Krishnamurthy P, Subramanian V, Singh M, Singh K. Beta 1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Hypertension 2007; 49:865-872.
11. Bossy B, Bossy-Wetzel E, Reichardt LF. Characterization of the integrin alpha 8 subunit: a new integrin beta 1-associated subunit, which is prominently expressed on axons and on cells in contact with basal laminae in chick embryos. EMBO J 1991; 10:2375-2385.
12. Schnapp LM, Hatch N, Ramos DM, Klimanskaya IV, Sheppard D, Pytela R. The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin. J Biol Chem 1995; 270:23196-23202.
13. Denda S, Reichardt LF, Muller U. Identification of osteopontin as a novel ligand for the integrin alpha 8 beta 1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 1998; 9:1425-1435.
14. Brandenberger R, Schmidt A, Linton J, Wang D, Backus C, Denda S, Muller U, Reichardt LF. Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha 8 beta 1 in the embryonic kidney. J Cell Biol 2001; 154:447-458.
15. Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G. Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis. Am J Physiol Heart Circ Physiol 2005; 289:H982-H991.
16. Schnapp LM, Breuss JM, Ramos DM, Sheppard D, Pytela R. Sequence and tissue distribution of the human integrin alpha 8 subunit: a beta 1-associated alpha subunit expressed in smooth muscle cells. J Cell Sci 1995; 108:537-544.
17. Hartner A, Cordasic N, Klanke B, Muller U, Sterzel RB, Hilgers KF. The alpha 8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease. Am J Pathol 2002; 160:861-867.
18. Levine D, Rockey DC, Milner TA, Breuss JM, Fallon JT, Schnapp LM. Expression of the integrin alpha 8 beta 1 during pulmonary and hepatic fibrosis. Am J Pathol 2000; 156:1927-1935.
19. Bouzeghrane F, Mercure C, Reudelhuber TL, Thibault G. Alpha 8 beta 1 integrin is upregulated in myofibroblasts of fibrotic and scarring myocardium. J Mol Cell Cardiol 2004; 36:343-353.
20. Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 1992; 120:893-901.
21. Neumann S, Huse K, Semrau R, Diegeler A, Gebhardt R, Buniatian GH, Scholz GH. Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro. Hypertension 2002; 39:756-760.
22. Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF. Integrin alpha 8 beta 1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 1997; 88:603-613.
23. Haas CS, Amann K, Schittny J, Blaser B, Muller U, Hartner A. Glomerular and renal vascular structural changes in alpha 8 integrin-deficient mice. J Am Soc Nephrol 2003; 14:2288-2296.
24. Hartner A, Marek I, Cordasic N, Haas C, Schocklmann H, Hulsmann-Volkert G, Plasa I, Rascher W, Hilgers KF, Amann K. Glomerular regeneration is delayed in nephritic alpha 8 integrin-deficient mice: contribution of alpha 8 integrin to the regulation of mesangial cell apoptosis. Am J Nephrol 2008; 28:168-178.
25. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995; 25:1111-1115.
26. Kleinman JG, Beshensky A, Worcester EM, Brown D. Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 1995; 47:1585-1596.
27. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 1992; 7:1029-1036.
28. Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006; 17:2992-2998.
29. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005; 45:657-687.
30. Okada H, Ban S, Nagao S, Takahashi H, Suzuki H, Neilson EG. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 2000; 58:587-597.
31. Thibault G, Lacombe MJ, Schnapp LM, Lacasse A, Bouzeghrane F, Lapalme G. Upregulation of alpha 8 beta 1 integrin in cardiac fibroblast by angiotensin II and transforming growth factor-beta 1. Am J Physiol Cell Physiol 2001; 281: C1457-C1467.
32. Bieritz B, Spessotto P, Colombatti A, Jahn A, Prols F, Hartner A. Role of alpha 8 integrin in mesangial cell adhesion, migration, and proliferation. Kidney Int 2003; 64:119-127.
33. Choi ET, Khan MF, Leidenfrost JE, Collins ET, Boc KP, Villa BR, Novack DV, Parks WC, Abendschein DR. Beta 3 integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice. Circulation 2004; 109:1564-1569.
34. Xie Z, Singh M, Singh K. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 2004; 44:826-831.
35. Lenga Y, Koh A, Perera AS, McCulloch CA, Sodek J, Zohar R. Osteopontin expression is required for myofibroblast differentiation. Circ Res 2008; 102:319-327.
36. Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E, Hsueh WA. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 1997; 96:3063-3071.
37. Nystrom T, Duner P, Hultgardh-Nilsson A. A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp Cell Res 2007; 313:1149-1160.
38. Nakamachi T, Nomiyama T, Gizard F, Heywood EB, Jones KL, Zhao Y, Fuentes L, Takebayashi K, Aso Y, Staels B, Inukai T, Bruemmer D. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes. Diabetes 2007; 56: 1662-1670.